SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-17-003280
Filing Date
2017-04-12
Accepted
2017-04-12 17:44:26
Documents
1
Period of Report
2017-04-11

Document Format Files

Seq Description Document Type Size
1 FORM4 section16.html 4  
1 FORM4 section16.xml 4 3225
  Complete submission text file 0001654954-17-003280.txt   4901
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O XTL BIOPHARMACEUTICALS LTD 711 EXECUTIVE BLVD., SUITE Q VALLEY COTTAGE NY 10989
Business Address
KENNEDY WILLIAM JAMES (Reporting) CIK: 0001448888 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 17758780